|
gptkbp:instanceOf
|
antidepressant
|
|
gptkbp:approvedBy
|
1961
|
|
gptkbp:ATCCode
|
N06AA06
|
|
gptkbp:brand
|
gptkb:Surmontil
|
|
gptkbp:CASNumber
|
739-71-9
|
|
gptkbp:category
|
antihistamine
antidepressant
tricyclic compound
|
|
gptkbp:chemicalFormula
|
C20H26N2
|
|
gptkbp:contraindication
|
gptkb:arrhythmias
recent myocardial infarction
mania
|
|
gptkbp:discoveredBy
|
gptkb:Ciba-Geigy
|
|
gptkbp:eliminationHalfLife
|
8–24 hours
|
|
gptkbp:excretion
|
urine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
trimipramine
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
antihistamine
norepinephrine reuptake inhibitor
anticholinergic
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
294.44 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
95%
|
|
gptkbp:PubChem_CID
|
5556
DB00726
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
constipation
dizziness
weight gain
drowsiness
dry mouth
|
|
gptkbp:synonym
|
gptkb:Surmontil
trimipramine maleate
|
|
gptkbp:UNII
|
3Z8ZQ1B41X
|
|
gptkbp:usedFor
|
gptkb:depression
insomnia
anxiety disorders
|
|
gptkbp:bfsParent
|
gptkb:tricyclic_antidepressants
|
|
gptkbp:bfsLayer
|
6
|